SHPH Q2 2024 Earnings — Shuttle Pharmaceuticals Holdings, Inc. Revenue & Financial Results | Market Cap Arena

SHPHShuttle Pharmaceuticals Holdings, Inc.

$1M

Q2 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$1M

Net Income

-$2M

EPS (Diluted)

$-0.20

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$71,162

Balance Sheet

Total Assets

$3M

Total Liabilities

$2M

Stockholders' Equity

$801,434

Cash & Equivalents

$695,594

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$1M	-$1M	-1.2%
Net Income	-$2M	-$2M	+7.0%